RASSF8-AS1

Across TCGA pan-cancer cohorts, RASSF8-AS1 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated RASSF8-AS1 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher RASSF8-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated RASSF8-AS1 expression acts as an unfavorable survival marker, although some lineages such as MESO and UCS show a favorable association.

MESO, UCS, and LUSC are the cancer types where RASSF8-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	All	0.532	0.256	<.001	71	view →
UCS	OS	Median	III,IV	0.672	0.239	.001	52	view →
LUSC	DFS	Median	III,IV	0.542	0.767	.003	51	view →
PAAD	OS	Tertile	All	0.594	0.279	<.001	41	view →
KIRC	DFS	Median	II,III,IV	0.630	0.751	.002	40	view →
KIRP	DFS	Median	IV	0.685	0.040	.002	37	view →
STAD	OS	Tertile	All	0.584	0.830	.004	33	view →
BRCA	DFS	Quartile	III,IV	0.869	0.689	.003	32	view →
SKCM	DFS	Median	II,III,IV	0.277	0.174	.002	28	view →
KICH	OS	Quartile	All	0.396	1.000	<.001	22	view →
LGG	OS	Quartile	All	0.714	0.945	<.001	22	view →
ACC	DFS	Quartile	All	0.659	0.929	.019	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

RASSF8-AS1–MESO (OS)

Open the MESO breakdown →